| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 16.519 | 23.435 | 24.824 | 42.256 | 55.923 | 48.050 | 51.637 | 24.869 | 11.147 | 29.116 |
| Total Income - EUR | 16.519 | 23.435 | 24.824 | 42.256 | 55.923 | 48.050 | 51.637 | 24.869 | 11.147 | 29.159 |
| Total Expenses - EUR | 16.865 | 21.312 | 24.098 | 39.252 | 42.106 | 32.146 | 35.020 | 31.364 | 19.858 | 27.253 |
| Gross Profit/Loss - EUR | -346 | 2.123 | 727 | 3.004 | 13.817 | 15.903 | 16.617 | -6.495 | -8.711 | 1.906 |
| Net Profit/Loss - EUR | -842 | 1.889 | 479 | 2.583 | 13.258 | 15.563 | 16.235 | -6.707 | -8.817 | 1.582 |
| Employees | 3 | 3 | 4 | 5 | 5 | 3 | 3 | 3 | 1 | 1 |
Check the financial reports for the company - Dr. Rizon Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 0 | 0 | 1.241 | 1.063 | 889 | 741 | 589 | 1.475 |
| Current Assets | 3.915 | 3.097 | 2.129 | 4.683 | 14.696 | 18.950 | 24.050 | 4.731 | 2.737 | 4.876 |
| Inventories | 3.701 | 980 | 780 | 0 | 0 | 0 | 0 | 73 | 86 | 0 |
| Receivables | 213 | 0 | 0 | 34 | 0 | 0 | 22.274 | 3.495 | 1.902 | 1.977 |
| Cash | 0 | 2.116 | 1.349 | 4.649 | 14.696 | 18.950 | 1.776 | 1.163 | 749 | 2.899 |
| Shareholders Funds | -286 | 1.606 | 744 | 2.635 | 13.308 | 18.282 | 22.953 | 3.848 | -5.020 | -3.410 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 4.200 | 1.490 | 1.385 | 2.048 | 2.628 | 1.734 | 1.987 | 1.625 | 8.346 | 9.850 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8623 - 8623" | |||||||||
| CAEN Financial Year |
8623
|
|||||||||
Comments - Dr. Rizon Srl